Market Research Reports, Business Consulting Services & Analytics

With the rise in demand for patients undergoing organ transplant procedures, there has been a growth in the Kaposi sarcoma treatment market

HYDERABAD, TELANGANA, INDIA, January 11, 2023 /EINPresswire.com/ -- The Kaposi Sarcoma Market size is valued at $122.4 million and is anticipated to grow at a CAGR of 4.12% during the forecast period 2020-2025. The Kaposi Sarcoma Market growth rate is attributed to the rising incidence of cancer. Kaposi sarcoma (KS) is cancer that develops from the cells that line lymph or blood vessels, abnormal cells of KS form purple, red, or brown blotches or tumours on the skin called lesions. As, Kaposi sarcoma is easily caught by a body with a weaker immune system, the chances of Kaposi sarcoma occurrence increase, which in turn fuels the market’s growth. From improvements made on reduction in drug resistance, lowering failure rate, few side effects, and the decreasing case-fatality ratios to the growing emphasis on combination therapy is anticipated to propel the Kaposi Sarcoma Market during the forecast period 2020-2025.

Click here to browse the complete report summary:
https://www.industryarc.com/Report/17349/kaposi-sarcoma-market.html

Key Takeaways

1. North America dominated the Kaposi Sarcoma Market with a share of 38%.

2. The factors such as rising research and development activities in this field and technological advancements, increasing mergers and acquisitions and strategic collaboration are among the major factor projected to impel the growth of the Kaposi Sarcoma Market.

3. An increase in demand for food & beverage products with an extended shelf life, marginal nutritional changes in products such as milk, and a reduction in logistics and storage costs are the key factors owing to the growth in the segment during the forecast period 2020-2025.

Interested in knowing more relevant information? Click here:
https://www.industryarc.com/pdfdownload.php?id=17349

Segmental Analysis:

1. Antiretroviral Therapy (HAART) segment held the largest share in the market owing to a rising incidence rate of AIDS-associated Kaposi sarcoma over other types. Also, there has been a rising preference for this treatment and the high cost of treatment is anticipated to bolster the market growth. Furthermore, for people with epidemic Kaposi sarcoma, antiretroviral treatment (ART) for HIV/AIDS is usually used before any other treatments to treat the tumour and reduce symptoms and rarely, ART can make preexisting infections and the Kaposi sarcoma worse. The segment is poised to grow at a CAGR of 3.44%

2. North America dominated the Kaposi Sarcoma Market with a share of 38%. The application of Kaposi Sarcoma has grown rapidly over the last few years owing to the presence of a large number of leading players and the increasing costs of drugs. In addition, the easy availability of advanced drugs and technologically advanced healthcare continue to expand its market. With the increasing prevalence of Kaposi sarcoma and HIV, The USFDA granted breakthrough therapy designation to Celgene’s pomalidomide (Pomalyst) for use as a treatment for patients with HIV-positive Kaposi sarcoma who have received prior chemotherapy, as well as patients with HIV-negative Kaposi sarcoma. Moreover, there is a high number of R&D initiatives undergoing the treatment and the diagnosis of Kaposi sarcoma to cater for the Kaposi Sarcoma Market in the forecast period of 2020-2025.

Competitive Landscape:

The top 5 players in the Kaposi Sarcoma Industry are -

1. Eli Lilly and Company
2. Pfizer
3. Bristol-Myers Squibb
4. Johnson & Johnson
5. GlaxoSmithKline

Click on the following link to buy the Kaposi Sarcoma Market Report:
https://www.industryarc.com/reports/request-quote?id=17349

Why Choose IndustryARC?

IndustryARC is one of the leading market research and consulting firms in the world. It produces over 500 unique market reports annually. If you are looking for a detailed overview of a particular market, you can simply connect with the team at IndustryARC. You can not only buy your preferred market report from the website but also get personalized assistance on specific reports.

Related Reports

A. Paclitaxel Injection Market
https://www.industryarc.com/Report/17536/paclitaxel-injection-market.html

B. Latin America Oncology Drugs Market
https://www.industryarc.com/Report/19794/latam-oncology-drugs-market.html

Contact Us:
Mr Venkat Reddy
IndustryARC
Email: venkat@industryarc.com, sales@industryarc.com
USA: (+1) 970-236-3677, (+1) 815-656-4596
IND: (+91) 40-485-49062

Venkat Reddy
IndustryARC
+1 614-588-8538
venkat@industryarc.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.